This overview provides a thorough review of current treatment approaches for first-line management of nononcogenic addicted non–small cell lung cancer. We also address pertinent clinical ...

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

Please provide your email address to receive an email when new articles are posted on . Newly announced ACR guidelines recommend against glucocorticoids as first-line therapy for interstitial lung ...